Andrew B. Nixon,Herbert I. Hurwitz,Stephanie Mackey Cushman,Chen Jiang,Ivo Shterev,Kouros Owzar,Ace J. Hatch,Alexander B. Sibley
申请号：
US14703535
公开号：
US20160024585A1
申请日:
2015.05.04
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present disclosure provides biomarkers, and methods of using such biomarkers, that are predictive for efficacy of and resistance to an EGFR targeting agent, such as cetuximab, or prognostic with respect to cancer survival.
